# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049098
Filing Date
2024-04-26
Accepted
2024-04-26 16:06:37
Documents
39
Period of Report
2024-04-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | apls-20240422.htm iXBRL | DEF 14A | 1855525
2 | GRAPHIC | img139075131_0.jpg | GRAPHIC | 27776
3 | GRAPHIC | img139075131_1.jpg | GRAPHIC | 2500
4 | GRAPHIC | img139075131_2.jpg | GRAPHIC | 3799
5 | GRAPHIC | img139075131_3.jpg | GRAPHIC | 2353
6 | GRAPHIC | img139075131_4.jpg | GRAPHIC | 3285
7 | GRAPHIC | img139075131_5.jpg | GRAPHIC | 2427
8 | GRAPHIC | img139075131_6.jpg | GRAPHIC | 14409
9 | GRAPHIC | img139075131_7.jpg | GRAPHIC | 14167
10 | GRAPHIC | img139075131_8.jpg | GRAPHIC | 13059
11 | GRAPHIC | img139075131_9.jpg | GRAPHIC | 15051
12 | GRAPHIC | img139075131_10.jpg | GRAPHIC | 16338
13 | GRAPHIC | img139075131_11.jpg | GRAPHIC | 12706
14 | GRAPHIC | img139075131_12.jpg | GRAPHIC | 10241
15 | GRAPHIC | img139075131_13.jpg | GRAPHIC | 7993
16 | GRAPHIC | img139075131_14.jpg | GRAPHIC | 44664
17 | GRAPHIC | img139075131_15.jpg | GRAPHIC | 20348
18 | GRAPHIC | img139075131_16.jpg | GRAPHIC | 53524
19 | GRAPHIC | img139075131_17.jpg | GRAPHIC | 9522
20 | GRAPHIC | img139075131_18.jpg | GRAPHIC | 66417
21 | GRAPHIC | img139075131_19.jpg | GRAPHIC | 8619
22 | GRAPHIC | img139075131_20.jpg | GRAPHIC | 11054
23 | GRAPHIC | img139075131_21.jpg | GRAPHIC | 10201
24 | GRAPHIC | img139075131_22.jpg | GRAPHIC | 23040
25 | GRAPHIC | img139075131_23.jpg | GRAPHIC | 22061
26 | GRAPHIC | img139075131_24.jpg | GRAPHIC | 24628
27 | GRAPHIC | img139075131_25.jpg | GRAPHIC | 17326
28 | GRAPHIC | img139075131_26.jpg | GRAPHIC | 463993
29 | GRAPHIC | img139075131_27.jpg | GRAPHIC | 247523
| Complete submission text file | 0000950170-24-049098.txt |  | 5851861

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
30 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | apls-20240422.xsd | EX-101.SCH | 53904
42 | EXTRACTED XBRL INSTANCE DOCUMENT | apls-20240422_htm.xml | XML | 376935

Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38276 | Film No.: 24883621
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)